More than 2.69 billion doses of the new crown vaccine have been vaccinated across the country, and the number of people who have completed the whole course of vaccination has exceeded 1.19 billion. The latest news from the joint prevention and control mechanism of the State Council shows that the vaccination rate in my country has reached more than 80%.
Building a solid population immune barrier is the fundamental strategy to defeat the epidemic.
Under the strong leadership of the CPC Central Committee with Comrade Xi Jinping at its core, China has fought the epidemic with resolute courage and determination, scientifically and accurately, and has always practiced the concept of “people first, life first”, and joined hands to build a community of shared future for mankind to overcome the difficulties together.
This is a prevention and control strategy that puts the protection of people’s health in the most prominent position-
From high-risk and key groups to the general population, from the elderly over 60 years old to children aged 3 to 11, China has completed the number of people who have completed the new crown vaccination in the world for more than a year, and the vaccination speed ranks among the top in the world.
This is an all-round race against the fast-spreading and mutating new coronavirus.
Mass vaccination helps control the chain of virus transmission in a short period, effectively reducing severe cases and deaths; 2 billion doses of vaccines will be provided to the world this year… China is striving to balance prevention and development while striving to bridge the world’s “immunity gap” “.
The power of China has built the “Great Wall of Immunity” to fight the epidemic.
Put the protection of people’s health as a high priority
Xiashi Town, Pingxiang City, Guangxi Province, is located on the frontier. One day in December, there was still a queue at the new crown vaccination point of the town center health center. “Recently, we have been concentrating on vaccinating primary and middle school students.” Huang Meilan, head of the health center, said, “At peak times, about 450 people can be vaccinated a day.”
According to data from the special vaccination class of the Guangxi Epidemic Prevention and Control Headquarters, as of December 13, a total of 44.007 million people in Guangxi had been vaccinated against the new crown vaccine, and the vaccination coverage rate of people over the age of 3 reached 91.3%.
Primary and secondary school students in Xiashi Town, Pingxiang City, Guangxi Province are vaccinated (photographed on November 18). Xinhua News Agency (Photo courtesy of the Central Health Center of Xashi Town, Pingxiang City)
Looking at the country, as of December 20, the cumulative number of reported doses of the new crown vaccine has exceeded 2.69 billion. At the same time, dozens of local sporadic cases and clustered outbreaks were quickly extinguished across the country. An important reason that disease control experts have concluded that the epidemic can be controlled in a relatively short period is the relatively high vaccination rate in the country. “We have been thinking about how to control the epidemic at a higher level, at a lower cost, and in a shorter time.” Ma Xiaowei, director of the National Health Commission, said that the early deployment of people, objects, and the environment is an effective approach to prevention and control in society. It is also necessary to insist that vaccines play an important role in blocking the spread of the new coronavirus and preventing the occurrence of severe diseases.
In the face of the COVID-19 epidemic, the most serious infectious disease pandemic that has occurred in the world in a century, China has always placed the protection of people’s health as a high priority and has regarded vaccine research and development and vaccination as an important basis for protecting people’s health.
This is a vivid embodiment of the Chinese Communist Party’s “people first” ruling philosophy——
At the beginning of the outbreak, at the deployment meeting on coordinating the prevention and control of the new crown pneumonia epidemic and economic and social development, General Secretary Xi Jinping emphasized that it is necessary to increase the research and development of drugs and vaccines.
Start vaccine research and development at the first time; free vaccination for the whole people; under the premise of safety and science, no group will be left behind; temporary vaccination points, mobile vaccination points, and key places for door-to-door vaccination, all for the convenience and benefit of the people… China is at every key node. , has invested huge resources in this vaccine “big test” in a timely and decisive manner.
Primary and secondary school students in Xiashi Town, Pingxiang City, Guangxi Province are vaccinated (photographed on November 18). Xinhua News Agency (Photo courtesy of the Central Health Center of Xashi Town, Pingxiang City)
“In the face of a new infectious disease like the new crown pneumonia, China’s prevention and control strategy first considers the people first and life first, and never takes chances.” Zheng Zhongwei, head of the vaccine research and development team of the joint prevention and control mechanism of the State Council Say.
This is the precious result of the firm command and efficient coordination of “one game of chess across the country”——
On February 15, 2020, a special class for vaccine research and development under the joint prevention and control mechanism scientific research team of the State Council was established, and the five technical routes for vaccine research and development were accelerated simultaneously;
On December 30, 2020, my country’s first new crown vaccine was approved for listing with conditions; the next day, the news of the free vaccination of the new crown vaccine was “officially announced”;
On March 24, 2021, the daily reporting system of new crown vaccination data was launched, and the National Health and Health Commission began to publish the total number of vaccinations on the official website every day;
The amount of inoculation from 100 million doses to 200 million doses took 25 days; from 200 million doses to 300 million doses, it took 16 days; next, 9 days, 7 days, 5 days…every 100 million doses Dosage times are getting shorter and shorter. Behind the “accelerated run” of vaccination is the meticulous and thoughtful policy arrangement from all over the country, racing against time and fighting against the disease; it is the hard work of the “soldiers in white” to ensure the safety of vaccination; it is the 1.4 billion people who work together to help build a strong anti-epidemic barrier and offer “a helping hand”.
Staff work in the sub-packaging workshop of the new coronavirus inactivated vaccine of Sinopharm China Bio-Beijing Institute of Biological Products (photo taken on December 25, 2020). Photo by Xinhua News Agency reporter Zhang Yuwei
This is an important support for balancing epidemic prevention and control with economic and social development——
In early November, Shanghai. The “four-leaf clover”-shaped National Exhibition Center was crowded, and the 4th China International Import Expo was held as scheduled. In 6 days, nearly 3,000 exhibitors from 127 countries and regions gathered, with a total intentional transaction of US$70.72 billion.
The China International Fair for Trade in Services and the China Import and Export Fair (Canton Fair) are also held as scheduled… On the one hand, the global epidemic fluctuates and fluctuates, and on the other hand, the domestic “dynamic clearing” and the epidemic are quickly extinguished together. China’s epidemic prevention and control The relationship between economic and social development has been well balanced.
“In addition to social public health interventions, another powerful tool for my country’s epidemic prevention and control is vaccination.” Liang Wannian, head of the expert group of the National Health Commission’s New Coronary Pneumonia Epidemic Response Leading Group, said that strict social prevention and control measures in China are being implemented. To gain a time window for vaccination and building a population immune barrier, and large-scale vaccination of vaccines also creates an important premise for the adjustment of future prevention and control strategies.
Put the people’s health account above the economic benefit account
Hefei, Anhui, Zhifeilong Kema Biopharmaceutical Co., Ltd.
From March 2021, it will be lit almost every day. Vaccines are continuously “flying” on the production line, from the production of raw liquid, preparation of preparations, to the packaging of finished products, and refrigerated storage.
Inactivated vaccines, recombinant protein vaccines, attenuated influenza virus vector vaccines, adenovirus vector vaccines, nucleic acid vaccines… Since the outbreak, the vaccine research and development special class has developed five technical routes simultaneously to improve the overall success rate of new crown vaccine research and development.
On the new crown vaccine production line of Anhui Zhifeilong Kema Biopharmaceutical Co., Ltd., the staff puts the vaccine into the conveyor belt (photographed on May 25). Photo by Xinhua News Agency reporter Zhang Duan
From the decisive decision to conduct vaccine research and development in the early stage of the outbreak to the timely promotion of free vaccination for the entire population, my country’s new crown vaccine has always been at the forefront of the world, regardless of whether it is developed or vaccinated.
“It only counts the people’s health account, not the economic benefit account.” Zheng Zhongwei said that enterprises and research teams have devoted themselves to vaccine development and production without hesitation, and jointly promoted vaccine research and development in China.
On the production line of the new crown vaccine of Anhui Zhifeilong Kema Biopharmaceutical Co., Ltd., the staff manually tested the vaccine (photographed on May 20). Photo by Xinhua News Agency reporter Huang Bohan Day and night, researchers work tirelessly.
On January 19, 2020, Sinopharm Group Sino Bio established a scientific research leading group led by Yang Xiaoming, chief scientist of the “863” vaccine project of the Ministry of Science and Technology, and quickly deployed three research institutes to develop new crown vaccines on two technical routes.
On January 26, 2020, the second day of the new year, Academician Chen Wei was ordered to lead a team to Wuhan urgently.
Also just after New Year’s Eve, the first scientific research team of Beijing Kexing Zhongwei Biotechnology Co., Ltd. entered the P3 laboratory to start the development of the new coronavirus inactivated vaccine.
Focusing on vaccine research and development, the research teams are working day and night to minimize the research and development time on the premise of respecting science and ensuring safety.
“Series” changes to “parallel”, each unit cooperates to fight——
Before vaccines can be used in human clinical trials, they must first pass animal experiments. To this end, Chinese scientists established animal models such as mice and rhesus monkeys for the first time.
Due to the emergency of the epidemic, the State Food and Drug Administration has made preparations for emergency review and approval and organized an expert team to intervene early and follow up the R&D process synchronously.
The 8-hour work under normal conditions has become a 24-hour work; the “series” process of each link has become a comprehensive “parallel” of R&D units, animal experiment units, review and approval units, etc.; respect for science, and always keep vaccines safe Effectively placed in an important position… China’s new crown vaccine research and development have achieved “acceleration, but no omission”.
On the production line of the new crown vaccine of Anhui Zhifeilong Kema Biopharmaceutical Co., Ltd., the staff packs the vaccine (photographed on May 20). Photo by Xinhua News Agency reporter Huang Bohan Increase production and capacity to ensure large-scale supply of vaccines.
Vaccine companies organize production at full capacity; relevant departments and localities have sent service guarantee teams to companies to promote the formulation of plans to increase production and capacity; strictly implement the quality management system to ensure the safety and stability of vaccine quality under large-scale and high-volume…
“The achievements of China’s vaccines can be summed up in four words, namely ‘dare, early, fast, and hard work’.” said Liu Jingzhen, chairman of China National Pharmaceutical Group Co., Ltd. “Early” means early deployment, early start-up, and early investment; “fast” means fast R&D, fast production, and fast use; “fighting” means fighting time, speed, and hard work.
The person in charge of the Ministry of Industry and Information Technology said that the quality and safety of vaccines should always be the first priority, and should be placed in the primary position of production and supply.
On the new crown vaccine production line of Anhui Zhifeilong Kema Biopharmaceutical Co., Ltd., the staff manually tested the vaccine (photographed on May 25). Photo by Xinhua News Agency reporter Zhang Duan
“It is precise because of the effective use of our institutional advantages and cultural advantages that innovations in mechanisms such as ‘series’ to ‘parallel’ and ‘research and review linkage’ can be realized.” Zeng Yixin, deputy director of the National Health Commission, said that we will actively promote the follow-up of the new crown vaccine. Related research, including real-world research, immune persistence research, etc. At the same time, plan ahead, closely monitor the mutation of the virus, and do a good job in the research and development of vaccines against severe variants of the new coronavirus in advance.
This is the new crown vaccine production line of Anhui Zhifeilong Kema Biopharmaceutical Co., Ltd. (photographed on May 25). Photo by Xinhua News Agency reporter Zhang Duan
Bridging the “immunity gap” and actively supporting the global fight against the epidemic
Banning flights, restricting travel, blocking borders… The emergence of the new coronavirus variant Omicron has quickly attracted global attention, and many countries that have relaxed control before have upgraded their epidemic prevention measures.
Mass vaccination is recognized by the scientific community as the most effective and economical means to block the spread of the new coronavirus, reduce the rate of mutation of the new coronavirus, and ultimately end the pandemic.
“Inoculation must form an immune barrier to play its greatest role.” Wang Huaqing, the chief expert of the immunization program at the Chinese Center for Disease Control and Prevention, said that the more people vaccinated, the stronger the immune barrier will be established; the faster the vaccination, the sooner the immune barrier will be formed.
But for some underdeveloped regions, it is not easy to vaccinate against the new crown on a large scale. Accessibility and affordability are like two “blockers” that delineate “immunity depressions” on different continents.
The World Health Organization has warned that the longer the unequal distribution of vaccines persists, the greater the spread of the virus and the greater the likelihood of more variants of the virus.
Workers pack the locally produced Kexing vaccine at the Fama Company’s bottling plant on the outskirts of Kuala Lumpur, Malaysia (photo taken on October 5). Photo by Xinhua News Agency reporter Zhu Wei
One by one, the promises are loud and clear—
“China’s vaccine will become a global public product”, on May 18, 2020, news was widely reported by multinational media. At the opening ceremony of the video conference of the 73rd World Health Assembly held on the same day, China made a solemn commitment.
A year later, on May 21, 2021, at the Global Health Summit, China once again announced to the world: “It will do its best to provide more vaccines to the outside world.”
Staff work in Kexing Zhongwei’s new crown vaccine packaging workshop (photo taken on January 6, 2021). Photo by Xinhua News Agency reporter Zhang Yuwei
A set of numbers, it’s really–
As of early December, China has provided more than 1.85 billion doses of vaccines to more than 120 countries and international organizations, will provide 2 billion doses this year, and donated $100 million to the “New Crown Vaccine Implementation Plan”.
In addition, jointly produce vaccines with about 20 developing countries, so that Chinese vaccines can reach more countries at a faster speed and at a lower cost; provide 150 million doses of new crown vaccine to ASEAN countries free of charge; provide another 1 billion doses to Africa Vaccines, of which 600 million doses are free to aid… China keeps its promises and will do what it says.
Workers carry the new crown vaccine supplied by China Sinopharm through the “New Crown Vaccine Implementation Plan” at Abidjan International Airport in Cote d’Ivoire (photo taken on September 18, 2021). Published by Xinhua News Agency (Photo by Ivan Song)
A series of propositions, exciting –
Increase support for African countries and strengthen global public health governance; abandon “vaccine nationalism” and solve the problems of vaccine production capacity and distribution; uphold the concept of a community of human health…
“Let us join hands to promote the building of a community of human health and jointly safeguard a bright future for human health!” China’s voice has injected confidence into the world’s strengthening of public health governance. (Reporters Dong Ruifeng, Xu Penghang, Qiu Bingqing, Tan Xingxing, Chen Nuo)
